This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Analyzing the benefits and challenges of implementing direct-to-patient services in the clinicalsupplychain to help meet patient requirements, improve supplychain efficiency and accelerate speed to market.
The benefits of developing a patient-centric clinicalsupplychain.
Find out solutions to mitigate the impact from clinicalsupplychain risk and discover how to improve dynamic drug supply forecasting strategies. Enrolling study subjects, setting up patient randomization and managing drug supply are critical to the success of a clinical trial. .
7am PDT.
Although only a small number of gene therapies have reached the market thus far, the industry is poised to grow quickly over the next few years. As the clinical trials industry adapts to the rising demand, it must also tackle important challenges concerning the way advanced medicines like cell and gene therapies are handled.
This innovative platform aims to revolutionize the industry by seamlessly connecting providers, distributors and suppliers, providing unprecedented visibility into supply and demand information. Developed in collaboration with Palantir Technologies Inc., How Will Surgence Optimize the Healthcare SupplyChain?
company (NASDAQ: AMZN), announced that it is working with Pfizer to create innovative, cloud-based solutions with the potential to improve how new medicines are developed, manufactured, and distributed for testing in clinical trials. (AWS), an Amazon.com, Inc.
Therefore, the available patient pool of a majority Black population in Africa represents an invaluable opportunity to develop medical products for patients with unmet clinical needs. Therefore, they are open to clinical trials, because of the lack of costs that they have to put towards it. being African American, 3.4%
With many clinical trial participants from Ukraine leaving the country after the outbreak of the war, clinical research organisations (CROs) played a crucial role in ensuring trial continuity. Oximio’s team have worked around the clock to ensure continuity in the clinicalsupplychain in Ukraine.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content